Rhoshan Pharmaceuticals, Inc.

CIK 1756479 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Rhoshan Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Jul 22, 2026D/A0001756479-26-000003
Sep 11, 2024D/A0001756479-24-000001
Sep 22, 2023D0001756479-23-000001
Sep 23, 2019D0000905718-19-000783
Dec 27, 2018D0000905718-18-000991